SG Americas Securities
RVMD icon

SG Americas Securities’s Revolution Medicines RVMD Stock Holding History

SG Americas Securities’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.19M Sell
38,399
-15,027
-28% -$2.19M ﹤0.01% 962
2026
Q1 		$5.2M Buy
53,426
+36,703
+219% +$3.71M 0.01% 1031
2025
Q4 		$1.33M Buy
16,723
+6,009
+56% +$394K ﹤0.01% 1787
2025
Q3 		$500K Buy
10,714
+6,436
+150% +$252K ﹤0.01% 2119
2025
Q2 		$157K Sell
4,278
-13,825
-76% -$531K ﹤0.01% 2414
2025
Q1 		$640K Buy
18,103
+15,164
+516% +$616K ﹤0.01% 1571
2024
Q4 		$129K Sell
2,939
-28,515
-91% -$1.44M ﹤0.01% 2533
2024
Q3 		$1.43M Buy
31,454
+20,724
+193% +$902K 0.01% 829
2024
Q2 		$416K Buy
10,730
+1,601
+18% +$59.8K ﹤0.01% 1766
2024
Q1 		$294K Buy
9,129
+5,534
+154% +$164K ﹤0.01% 1708
2023
Q4 		$103K Sell
3,595
-54,206
-94% -$1.3M ﹤0.01% 2745
2023
Q3 		$1.6M Buy
+57,801
New +$1.71M 0.02% 905
2023
Q2 		– Sell
-26,811
Closed -$581K – 3043
2023
Q1 		$581K Buy
26,811
+3,007
+13% +$74K 0.01% 1605
2022
Q4 		$567K Sell
23,804
-165
-0.7% -$3.51K 0.01% 1431
2022
Q3 		$473K Sell
23,969
-14,663
-38% -$322K 0.01% 1598
2022
Q2 		$753K Buy
38,632
+31,690
+456% +$617K 0.01% 1572
2022
Q1 		$177K Buy
6,942
+2,251
+48% +$49K ﹤0.01% 2490
2021
Q4 		$118K Sell
4,691
-41,514
-90% -$1.17M ﹤0.01% 2986
2021
Q3 		$1.27M Buy
+46,205
New +$1.34M 0.01% 1696
2021
Q2 		– Sell
-9,813
Closed -$450K – 3185
2021
Q1 		$450K Buy
+9,813
New +$440K ﹤0.01% 2093
2020
Q4 		– Sell
-8,365
Closed -$291K – 3454
2020
Q3 		$291K Sell
8,365
-14,901
-64% -$413K ﹤0.01% 1950
2020
Q2 		$735K Buy
23,266
+18,282
+367% +$575K 0.01% 1720
2020
Q1 		$109K Buy
+4,984
New +$138K ﹤0.01% 2935

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

SG Americas Securities's RVMD Position: Q2 2026 in Review

SG Americas Securities reduced its Revolution Medicines (RVMD) stake by 28% in Q2 2026, selling an estimated $2.19M and leaving 38,399 shares worth $7.19M. The position accounts for ﹤0.01% of the portfolio, ranked #962.

SG Americas Securities first reported a position in RVMD in Q1 2020 and has held it in 23 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • SG Americas Securities held 38,399 shares of Revolution Medicines worth $7.19M as of Q2 2026.
  • SG Americas Securities sold 15,027 Revolution Medicines shares in Q2 2026, an estimated $2.19M.
  • Revolution Medicines made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #962 holding.
  • SG Americas Securities first reported a position in Revolution Medicines in Q1 2020 and has held it in 23 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.